two non-cross resistant polychemotherapic schedules (CMF + A) weresequentially used in 25 females with advanced breast cancer. positive rults (R.C +R.P.+ S) were obtained in 76% of patients. Responders showed a longer (16.3 mo.) survival than non -responders (8.2 mo.). Viceral dominant disease was more sensitive to therapy than bone dominat disease. However in bone disease, overall survival was not affected by response to therapy. No severe toxicity was observed with the polychemotherapy used
Risultati di uno schema sequenziale di polichemioterapia nel carcinoma mammario.
LIBERATI, Anna Marina;
1979
Abstract
two non-cross resistant polychemotherapic schedules (CMF + A) weresequentially used in 25 females with advanced breast cancer. positive rults (R.C +R.P.+ S) were obtained in 76% of patients. Responders showed a longer (16.3 mo.) survival than non -responders (8.2 mo.). Viceral dominant disease was more sensitive to therapy than bone dominat disease. However in bone disease, overall survival was not affected by response to therapy. No severe toxicity was observed with the polychemotherapy usedFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
